Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. | Available online http ccforum.eom content 13 3 R83 Research Procalcitonin to guide duration of antibiotic therapy in intensive care patients a randomized prospective controlled trial Marcel Hochreiter1 Thomas Kohler1 Anna Maria Schweiger2 Fritz Sixtus Keck2 3 Berthold Bein4 Tilman von Spiegel1 and Stefan Schroeder1 Department of Anesthesiology and Intensive Care Medicine West Coast Hospital Esmarchstrasse 50 25746 Heide Germany department of Laboratory Medicine and Clinical Chemistry West Coast Hospital Esmarchstrasse 50 25746 Heide Germany 3Medical Clinic West Coast Hospital Esmarchstr. 50 25746 Heide Germany department of Anesthesiology and Intensive Care Medicine University Hospital Schleswig-Holstein Campus Kiel Schwanenweg 21 24105 Kiel Germany Corresponding author Stefan Schroeder sschroeder@wkk-hei.de Received 24 Feb 2009 Revisions requested 18 Mar 2009 Revisions received 21 Mar 2009 Accepted 3 Jun 2009 Published 3 Jun 2009 Critical Care 2009 13 R83 doi 10.1186 cc7903 This article is online at http ccforum.com content 13 3 R83 2009 Hochreiter et al. licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Open Access Abstract Introduction The development of resistance by bacterial species is a compelling issue to reconsider indications and administration of antibiotic treatment. Adequate indications and duration of therapy are particularly important for the use of highly potent substances in the intensive care setting. Until recently no laboratory marker has been available to differentiate bacterial infection from viral or non-infectious inflammatory reaction however over the past years procalcitonin PCT is the first among a large array of inflammatory variables that offers this possibility. The present study aimed to .
